Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2006

  1. Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA Study

    International Journal of Clinical Practice, Vol. 60, Núm. 11, pp. 1364-1370

  2. Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice. The VIPE study

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 7, Núm. 4, pp. 236-242

2005

  1. Estudio PREVENCAT: Control del riesgo cardiovascular en atención primaria

    Medicina Clinica, Vol. 124, Núm. 11, pp. 406-410